Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Comparative study between intraarticular ostenil versus orthovisc
ISRCTN ISRCTN43185756
ClinicalTrials.gov identifier
Public title Comparative study between intraarticular ostenil versus orthovisc
Scientific title
Acronym N/A
Serial number at source N0237142757
Study hypothesis Which one is most effective in providing short to medium term relief for patients with osteoarthritis of the knee either ostenil or orthovisc, if used as a single course?
Lay summary
Ethics approval Not provided at time of registration
Study design Prospective masked observer randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Musculoskeletal Diseases: Osteoarthritis of the knee
Participants - inclusion criteria 73 patients will be entered in each arm of the trial. Selection of the study group will be from the group of patients diagnosed to have osteoarthritis of the knee. All eligible patients both male and female would be invited to participate. The total number of patients involved will be 146
Participants - exclusion criteria 1. Other known inflammatory arthropathies eg psoriasis, sero-negative arthropathies
2. Grade 4 osteoarthritis on the Kellgren score
3. Previous intra articular injections (except previous steroids or local anaesthetic)
4. Laxity or deformity
5. Uncontrolled diabetes, pregnancy, major existing medical problems, liver and renal diseases
6. Immunosuppressed and those on high dose steroids for any reason
7. Local infection at site and patients with gross pedal oedema
8. Patients with hypersensitivity to hyaluronic acid
9. Patients unwilling to participate or unable to give consent
Anticipated start date 01/05/2004
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material
Target number of participants 146
Interventions Intraarticular ostenil versus orthovisc
Primary outcome measure(s) 1. WOMAC - Western Ontario and McMaster Universities Arthritis Index
2. VAS - pain scale
Secondary outcome measure(s) Not provided at time of registration
Sources of funding St Helens and Knowsley Hospitals NHS Trust (UK) NHS R&D Support Funding
Trial website
Publications
Contact name Mr  VS  Dachepalli
  Address St Helens & Knowsley Hospitals NHS Trust
Orthopaedics
Whiston Hospital
  City/town Prescot
  Zip/Postcode L35 5DR
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 12/04/2011
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central